Guideline on Ovarian Stimulation in IVF/ICSI



Responsible Special Interest Group: 
SIG Reproductive Endocrinology 


Current status of the guideline:
 (last update: 21/05/2019) 
Deadline stakeholder review has passed. Thank you to everyone who contributed. All comments will be listed in the review report, with a response of the working group. If relevant, the guideline recommendations will be altered. If no change is made, the reasons for this will also be recorded. The review report will be published on the ESHRE website, and all reviewers will be listed in Annex 6 of the guideline.
The full guideline will be published here, after approval by the ESHRE Executive Committee, during the Annual Meeting in Vienna.

Scope of the guideline:

Ovarian stimulation is an integral part of assisted reproductive techniques. Ovarian stimulation is employed to induce development of multiple dominant follicles, and to mature more oocytes to improve chances for conception. The aim of this ESHRE guidelines project is to provide gynecologists, medical physicians and embryologists in the field of reproductive medicine, infertility and assisted reproduction with evidence-based information on the different options for Ovarian Stimulation in IVF/ICSI. Optimal ovarian response, live birth rates, safety, patient compliance and individualization will hereby be taken into account. A guideline group has been established (with many European experts) and 20 key questions formulated. Following a literature search, evidence will be graded and recommendations formulated.